Identifying the earliest druggable targets in parkinson's disease
Active Project Grant Awarded Last action
- Award ID
- HT94252410890
- Recipient
-
The University Of Auckland UEI F1EHWJFBEWL8
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $1,126,472
Award facts
- Assistance listing
- 12.420 Military Medical Research and Development
- Completion date 72% complete
- Place of performance
- New Zealand
Award details come from USAspending.gov.
About this award
The Department of the Army Medical Command awarded a $1,126,472 project grant under the Military Medical Research and Development (CFDA 12.420) program to The University of Auckland in New Zealand. The purpose of the grant is to identify the earliest druggable targets for Parkinson's disease. The award has a performance period from September 1, 2024 to August 31, 2027. As a prominent international research institution, The University of Auckland has established a strong track record of collaborating with U.S. federal agencies on advanced biomedical research initiatives. This project grant will leverage the university's expertise to advance the understanding and treatment of Parkinson's disease, with the potential to transform healthcare for military service members and the broader public.
Quick answers
Who received award HT94252410890?
HT94252410890 was awarded to The University Of Auckland by Defense Health Agency (Department of Defense) on September 1, 2024.
How much is award HT94252410890 worth?
$1,126,472 has been obligated on HT94252410890.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award